Patents

A strong intellectual property portfolio supports Hybrid Organ's technology covering the entire hybrid organ therapy value chain.  The patent coverage ensures key positions in tissue engineering and hybrid organs in medicine, analytical reactors, substance producing reactors and cell producing reactors.
The following patents cover legitimate claims on bioreactor constructions, manufacturing processes and applications:

* Gerlach J.: German Patent 4230194: 9.9.92
* Gerlach J.: 7 European Patents: 93114076.8: 2.9.1993
* Gerlach J.: Japanese Patent Aplication 6-205665
* Gerlach J.: US Patent Application 08/117,429: 9.7.93